<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Arq Bras Cardiol</journal-id><journal-id journal-id-type="iso-abbrev">Arq. Bras. Cardiol</journal-id><journal-id journal-id-type="publisher-id">abc</journal-id><journal-title-group><journal-title>Arquivos Brasileiros de Cardiologia</journal-title></journal-title-group><issn pub-type="ppub">0066-782X</issn><issn pub-type="epub">1678-4170</issn><publisher><publisher-name>Sociedade Brasileira de Cardiologia</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26351982</article-id><article-id pub-id-type="pmc">4651407</article-id><article-id pub-id-type="doi">10.5935/abc.20150110</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Does Ad Hoc Coronary Intervention Reduce Radiation Exposure? &#x02013; Analysis
of 568 Patients</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Truffa</surname><given-names>M&#x000e1;rcio A. M.</given-names></name><xref ref-type="aff" rid="aff01"/><xref ref-type="corresp" rid="c01"/></contrib><contrib contrib-type="author"><name><surname>Alves</surname><given-names>Gustavo M.P.</given-names></name><xref ref-type="aff" rid="aff01"/></contrib><contrib contrib-type="author"><name><surname>Bernardi</surname><given-names>Fernando</given-names></name><xref ref-type="aff" rid="aff01"/></contrib><contrib contrib-type="author"><name><surname>Esteves Filho</surname><given-names>Antonio</given-names></name><xref ref-type="aff" rid="aff01"/></contrib><contrib contrib-type="author"><name><surname>Ribeiro</surname><given-names>Expedito</given-names></name><xref ref-type="aff" rid="aff01"/></contrib><contrib contrib-type="author"><name><surname>Galon</surname><given-names>Micheli Z.</given-names></name><xref ref-type="aff" rid="aff01"/></contrib><contrib contrib-type="author"><name><surname>Spadaro</surname><given-names>Andr&#x000e9;</given-names></name><xref ref-type="aff" rid="aff01"/></contrib><contrib contrib-type="author"><name><surname>Kajita</surname><given-names>Luiz J.</given-names></name><xref ref-type="aff" rid="aff01"/></contrib><contrib contrib-type="author"><name><surname>Arrieta</surname><given-names>Raul</given-names></name><xref ref-type="aff" rid="aff01"/></contrib><contrib contrib-type="author"><name><surname>Lemos</surname><given-names>Pedro A.</given-names></name><xref ref-type="aff" rid="aff01"/></contrib><aff id="aff01">Instituto do Cora&#x000e7;&#x000e3;o - Hospital das Cl&#x000ed;nicas - Faculdade de Medicina da
Universidade de S&#x000e3;o Paulo (USP), S&#x000e3;o Paulo, SP &#x02212; Brazil</aff></contrib-group><author-notes><corresp id="c01"><bold>Mailing Address: M&#x000e1;rcio Augusto Meirelles Truffa</bold> Rua
das Orqu&#x000ed;deas, 96, Jardim Novo Mundo. Postal Code 13211-600, Jundia&#x000ed;, SP &#x02013; Brazil
E-mail: <email>marciotruffa@yahoo.com.br</email></corresp></author-notes><pub-date pub-type="epub-ppub"><month>11</month><year>2015</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><month>11</month><year>2015</year></pub-date><volume>105</volume><issue>5</issue><fpage>487</fpage><lpage>492</lpage><history><date date-type="received"><day>27</day><month>3</month><year>2015</year></date><date date-type="rev-recd"><day>14</day><month>4</month><year>2015</year></date><date date-type="accepted"><day>24</day><month>6</month><year>2015</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly
cited.</license-p></license></permissions><abstract><sec><title>Background</title><p>Advantages and disadvantages of ad hoc percutaneous coronary intervention have
been described. However little is known about the radiation exposure of that
procedure as compared with the staged intervention.</p></sec><sec><title>Objective</title><p>To compare the radiation dose of the ad hoc percutaneous coronary intervention
with that of the staged procedure</p></sec><sec><title>Methods</title><p>The dose-area product and total Kerma were measured, and the doses of the
diagnostic and therapeutic procedures were added. In addition, total fluoroscopic
time and number of acquisitions were evaluated.</p></sec><sec><title>Results</title><p>A total of 568 consecutive patients were treated with ad hoc percutaneous coronary
intervention (n = 320) or staged percutaneous coronary intervention (n = 248). On
admission, the ad hoc group had less hypertension (74.1% vs 81.9%; p = 0.035),
dyslipidemia (57.8% vs. 67.7%; p = 0.02) and three-vessel disease (38.8% vs.
50.4%; p = 0.015). The ad hoc group was exposed to significantly lower radiation
doses, even after baseline characteristic adjustment between both groups. The ad
hoc group was exposed to a total dose-area product of 119.7 &#x000b1; 70.7 Gycm<sup>2</sup>, while
the staged group, to 139.2 &#x000b1; 75.3 Gycm<sup>2</sup> (p &#x0003c; 0.001).</p></sec><sec><title>Conclusion</title><p>Ad hoc percutaneous coronary intervention reduced radiation exposure as compared
with diagnostic and therapeutic procedures performed at two separate times.</p></sec></abstract><kwd-group><kwd>Angioplasty, Balloon, Coronary</kwd><kwd>Cardiac, Catheterization</kwd><kwd>Coronary Angiography</kwd><kwd>Fluoroscopy</kwd><kwd>Radiation Monitoring</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Interventional cardiological procedures, such as coronary angiography and percutaneous
coronary intervention (PCI), are extremely important for diagnosis and treatment, have
been increasingly used, but, so far, no alternative to radiation for their performance
has been identified<sup><xref rid="r01" ref-type="bibr">1</xref></sup>.</p><p>The International Commission on Radiological Protection (ICRP) determines the risks of
radiation exposure in fluoroscopy-guided procedures. Those risks are related to skin
lesions (deterministic effects) and to an increase in the incidence of neoplasia
(stochastic effects)<sup><xref rid="r02" ref-type="bibr">2</xref>,<xref rid="r03" ref-type="bibr">3</xref></sup>. The use of radiological imaging has increased, which, in
association with the increase in life expectancy worldwide, is related to a considerable
risk of cancer<sup><xref rid="r04" ref-type="bibr">4</xref></sup>.</p><p>A series of advantages and disadvantages of <italic>ad hoc</italic> PCI, such as that
performed along with diagnostic catheterization, has been described. However, little is
known about the radiation exposure of that procedure as compared to that of staged
intervention, performed on a second occasion after the patient has undergone diagnostic
catheterization.</p><p>The radiation doses of coronary angiography and interventional procedures, such as
percutaneous coronary angioplasty, have been reported, mainly in complex procedures, the
greatest doses being those of angioplasty<sup><xref rid="r05" ref-type="bibr">5</xref>-<xref rid="r07" ref-type="bibr">7</xref></sup>. However, no study has
shown if the radiation doses of <italic>ad hoc</italic> and staged angioplasties
differ.</p><p>This study was aimed at comparing the radiation exposure of patients undergoing two
different PCI schemes: <italic>ad hoc</italic> and staged.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Study population</title><p>The present study included consecutive patients from one single center undergoing
<italic>ad hoc</italic> (Group 1) and staged (Group&#x000a0;2) PCI between July
1<sup>st</sup>, 2012 and December 31, 2012. The procedures were performed at an
academic institution, the Instituto do Cora&#x000e7;&#x000e3;o (Incor) of the Hospital das Cl&#x000ed;nicas
of the Medical School of the Universidade de S&#x000e3;o Paulo, by an attending physician
accompanied by interventional cardiology trainees.</p><p>Demographic and procedural data were obtained from the electronic medical records of
Incor and assessed in a historical prospective way. The following clinical variables
were included: patient-related: sex, age, risk factors, clinical findings motivating
catheterization, cardiac history and coronary anatomy; and procedure-related: number
of lesions treated and stents implanted, and coronary artery territory approached.
Both groups had clinically stable and unstable patients.</p></sec><sec><title>Measures of radiation exposure</title><p>Radiation exposure was expressed as follows: Kerma (kinetic energy released per unit
mass), which refers to the radiation beam delivered to the environment at a certain
point; and &#x02018;dose-area product&#x02019; (DAP), equivalent to the dose multiplied by the area
irradiated. Kerma was quantified in Gy, and DAP, in Gycm<sup>2</sup>. We used the DAP
because it bears a strong relationship with the dose effectively transmitted to the
patient<sup><xref rid="r06" ref-type="bibr">6</xref></sup>. Such measures are
integrated with the X-ray system and are available at the end of the procedure. In
addition, fluoroscopic time and number of acquisitions were computed and compared. In
the group of staged angioplasty, the radiation measurements of diagnostic coronary
angiography were added to those of angioplasty.</p><p>The procedures took place at the catheterization laboratory of Incor, which has five
rooms, four of which equipped with the Philips Allura Xper FD10 device, and one, with
the Philips Allura Xper FD20 device. The acquisition field was 15- to 25-cm diagonal.
The acquisition mode and number of frames varied between 15 and 30 frames/second.</p></sec><sec><title>Statistical analysis</title><p>The Statistical Package for the Social Science (SPSS) software was used for
statistical analysis. Continuous variables were expressed as mean and standard
deviation, and categorical variables, as percentage. The groups were compared by
using the non-parametric Mann-Whitney U test for continuous variables, and the
chi-square or Fisher exact test for categorical variables. At the end, the dependent
variable &#x02018;total DAP&#x02019; underwent multiple regression with generalized linear models
(GLM) for the dependent variable without normal distribution; gamma distribution,
with logarithmic link function and backward selection method, was used. The initial
model included the following predictive variables: procedure type (<italic>ad
hoc,</italic> 1; staged, 0); age (years); sex (male, 1; female, 0); systemic
arterial hypertension (yes, 1; no, 0); diabetes mellitus (yes, 1; no, 0);
dyslipidemia (yes, 1; no, 0); smoking habit (yes, 1; no, 0); previous acute
myocardial infarction (yes, 1; no, 0); previous PCI (yes, 1; no, 0); previous
coronary artery bypass graft surgery (yes, 1; no, 0); previous congestive heart
failure (yes, 1; no, 0); angiographic characteristic (single-, two-vessel: 0;
three-vessel: 1); use of drug-eluting stent (yes, 1; no, 0); angioplasty of left main
coronary artery (yes, 1; no, 0); angioplasty of anterior descending coronary artery
(yes, 1; no, 0); angioplasty of right coronary artery (yes, 1; no, 0); angioplasty of
circumflex coronary artery (yes, 1; no, 0); angioplasty of saphenous vein graft (yes,
1; no, 0); number of lesions (1, 0; 2 and 3, 1); number of stents (0, 1: 0; 2 to 5:
1); and total stent length (cm). The significance level adopted was &#x003b1; = 0.05.</p></sec></sec><sec><title>Result</title><p>This study included 568 patients, 320 of whom underwent <italic>ad hoc</italic>
procedures (Group 1) and 248, staged procedures (Group 2). <xref ref-type="table" rid="t01">Table 1</xref> shows the clinical and angiographic characteristics of the
groups as means and percentages. The&#x000a0;groups did not differ regarding risk factors for
DAC, except for dyslipidemia and arterial hypertension, more common in Group 2.</p><table-wrap id="t01" orientation="portrait" position="float"><label>Table 1</label><caption><p>Clinical, angiographic and procedural characteristics</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="5" align="left" rowspan="1">Total = 568</th><th align="center" rowspan="1" colspan="1">Ad hoc (n = 320)</th><th align="center" rowspan="1" colspan="1">Staged (n = 248)</th><th align="center" rowspan="1" colspan="1">p value</th></tr></thead><tbody><tr><td colspan="5" rowspan="1">Age (years)</td><td align="center" rowspan="1" colspan="1">63.3 &#x000b1; 12.00</td><td align="center" rowspan="1" colspan="1">63.9 &#x000b1; 11.43</td><td align="center" rowspan="1" colspan="1">0.567<xref ref-type="table-fn" rid="TFN01">*</xref></td></tr><tr><td colspan="5" rowspan="1">Male sex (%)</td><td align="center" rowspan="1" colspan="1">70.3</td><td align="center" rowspan="1" colspan="1">68.5</td><td align="center" rowspan="1" colspan="1">0.718<xref ref-type="table-fn" rid="TFN02">&#x02020;</xref></td></tr><tr style="border-bottom-style:solid; border-bottom-width:thin; border-top-style:solid; border-top-width:thin"><td colspan="8" rowspan="1">
<bold>Patient's characteristics (%)</bold>
</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">SAH</td><td align="center" rowspan="1" colspan="1">74.1</td><td align="center" rowspan="1" colspan="1">81.9</td><td align="center" rowspan="1" colspan="1">0.035<xref ref-type="table-fn" rid="TFN02">&#x02020;</xref></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">DM</td><td align="center" rowspan="1" colspan="1">37.5</td><td align="center" rowspan="1" colspan="1">41.9</td><td align="center" rowspan="1" colspan="1">0.324<xref ref-type="table-fn" rid="TFN02">&#x02020;</xref></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">DLP</td><td align="center" rowspan="1" colspan="1">57.8</td><td align="center" rowspan="1" colspan="1">67.7</td><td align="center" rowspan="1" colspan="1">0.020<xref ref-type="table-fn" rid="TFN02">&#x02020;</xref></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">Smoking</td><td align="center" rowspan="1" colspan="1">39.4</td><td align="center" rowspan="1" colspan="1">43.1</td><td align="center" rowspan="1" colspan="1">0.412<xref ref-type="table-fn" rid="TFN02">&#x02020;</xref></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">Previous AMI</td><td align="center" rowspan="1" colspan="1">30.0</td><td align="center" rowspan="1" colspan="1">30.6</td><td align="center" rowspan="1" colspan="1">0.941<xref ref-type="table-fn" rid="TFN02">&#x02020;</xref></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">Previous PCI</td><td align="center" rowspan="1" colspan="1">30.0</td><td align="center" rowspan="1" colspan="1">26.2</td><td align="center" rowspan="1" colspan="1">0.368<xref ref-type="table-fn" rid="TFN02">&#x02020;</xref></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">Previous CABG</td><td align="center" rowspan="1" colspan="1">17.8</td><td align="center" rowspan="1" colspan="1">19.8</td><td align="center" rowspan="1" colspan="1">0.630<xref ref-type="table-fn" rid="TFN02">&#x02020;</xref></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">Previous CHF</td><td align="center" rowspan="1" colspan="1">25.3</td><td align="center" rowspan="1" colspan="1">27.8</td><td align="center" rowspan="1" colspan="1">0.564<xref ref-type="table-fn" rid="TFN02">&#x02020;</xref></td></tr><tr style="border-bottom-style:solid; border-bottom-width:thin; border-top-style:solid; border-top-width:thin"><td colspan="5" rowspan="1">
<bold>Angiographic characteristics (%)</bold>
</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">0.015<xref ref-type="table-fn" rid="TFN03">&#x02021;</xref></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">Single-vessel</td><td align="center" rowspan="1" colspan="1">30.3</td><td align="center" rowspan="1" colspan="1">22.2</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">Two-vessel</td><td align="center" rowspan="1" colspan="1">30.9</td><td align="center" rowspan="1" colspan="1">27.4</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">Three-vessel</td><td align="center" rowspan="1" colspan="1">38.8</td><td align="center" rowspan="1" colspan="1">50.4</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr style="border-bottom-style:solid; border-bottom-width:thin; border-top-style:solid; border-top-width:thin"><td colspan="8" rowspan="1">
<bold>Procedural characteristics (%)</bold>
</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">DES<sup><xref ref-type="table-fn" rid="TFN04">a</xref></sup></td><td align="center" rowspan="1" colspan="1">20.5</td><td align="center" rowspan="1" colspan="1">32.7</td><td align="center" rowspan="1" colspan="1">0.001<xref ref-type="table-fn" rid="TFN02">&#x02020;</xref></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">LMC<sup><xref ref-type="table-fn" rid="TFN05">b</xref></sup></td><td align="center" rowspan="1" colspan="1">1.6</td><td align="center" rowspan="1" colspan="1">3.2</td><td align="center" rowspan="1" colspan="1">0.308<xref ref-type="table-fn" rid="TFN02">&#x02020;</xref></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">AD<sup><xref ref-type="table-fn" rid="TFN05">b</xref></sup></td><td align="center" rowspan="1" colspan="1">48.7</td><td align="center" rowspan="1" colspan="1">46.0</td><td align="center" rowspan="1" colspan="1">0.568<xref ref-type="table-fn" rid="TFN02">&#x02020;</xref></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">RC<sup><xref ref-type="table-fn" rid="TFN05">b</xref></sup></td><td align="center" rowspan="1" colspan="1">32.1</td><td align="center" rowspan="1" colspan="1">29.4</td><td align="center" rowspan="1" colspan="1">0.560<xref ref-type="table-fn" rid="TFN02">&#x02020;</xref></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">CX<sup><xref ref-type="table-fn" rid="TFN05">b</xref></sup></td><td align="center" rowspan="1" colspan="1">23.6</td><td align="center" rowspan="1" colspan="1">40.7</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.001<xref ref-type="table-fn" rid="TFN02">&#x02020;</xref></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">SVG<sup><xref ref-type="table-fn" rid="TFN05">b</xref></sup></td><td align="center" rowspan="1" colspan="1">6.9</td><td align="center" rowspan="1" colspan="1">4.0</td><td align="center" rowspan="1" colspan="1">0.196<xref ref-type="table-fn" rid="TFN02">&#x02020;</xref></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">Other vessels<sup><xref ref-type="table-fn" rid="TFN05">b</xref></sup></td><td align="center" rowspan="1" colspan="1">0.6</td><td align="center" rowspan="1" colspan="1">2.0</td><td align="center" rowspan="1" colspan="1">0.249<xref ref-type="table-fn" rid="TFN06">&#x000a7;</xref></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">Lesions (number)<sup><xref ref-type="table-fn" rid="TFN05">b</xref></sup></td><td align="center" rowspan="1" colspan="1">1.22 &#x000b1; 0.49</td><td align="center" rowspan="1" colspan="1">1.36 &#x000b1; 0.54</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.001<xref ref-type="table-fn" rid="TFN01">*</xref></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">Stents implanted (number)<sup><xref ref-type="table-fn" rid="TFN05">b</xref></sup></td><td align="center" rowspan="1" colspan="1">1.32 &#x000b1; 0.83</td><td align="center" rowspan="1" colspan="1">1.65 &#x000b1; 0.97</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.001<xref ref-type="table-fn" rid="TFN01">*</xref></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">Total stent length (cm)<sup><xref ref-type="table-fn" rid="TFN05">b</xref></sup></td><td align="center" rowspan="1" colspan="1">26.01 &#x000b1; 18.41</td><td align="center" rowspan="1" colspan="1">33.48 &#x000b1; 22.82</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.001<xref ref-type="table-fn" rid="TFN01">*</xref></td></tr></tbody></table><table-wrap-foot><fn id="TFN01"><label>*</label><p>Non-parametric Mann-Whitney U test;</p></fn><fn id="TFN02"><label>&#x02020;</label><p>Yates correction for 2 x 2 tables;</p></fn><fn id="TFN03"><label>&#x02021;</label><p>Pearson correlation;</p></fn><fn id="TFN04"><label>a</label><p>data from three patients of the ad hoc group missing;</p></fn><fn id="TFN05"><label>b</label><p>data from two patients of the ad hoc group missing;</p></fn><fn id="TFN06"><label>&#x000a7;</label><p>Fisher exact test. Results presented as mean (standard deviation) or
percentage.</p></fn><fn id="TFN07"><p>Results presented as mean (standard deviation) or percentage. SAH: Systemic
arterial hypertension; DM: Diabetes mellitus; DLP: Dyslipidemia; AMI: Acute
myocardial infarction; PCI: Percutaneous coronary intervention; CABG: Coronary
artery bypass graft surgery; CHF: Congestive heart failure; DES: Drug-eluting
stent; LMC: Left main coronary artery; AD: Anterior descending coronary artery;
RC: Right coronary artery; CX: Circumflex artery; SVG: Saphenous vein
graft.</p></fn></table-wrap-foot></table-wrap><p>Group 1 patients more often had single- and two-vessel angiographic characteristics than
Group 2 patients, in whom the three-vessel pattern predominated. Group 2 as compared to
Group 1 had a higher number of lesions treated (1.22 &#x000b1; 0.49 vs. 1.36 &#x000b1; 0.54; p &#x0003c;
0.001), requiring a greater number of stents (1.32 &#x000b1; 0.83 vs. 1.65 &#x000b1; 0.97; p &#x0003c; 0.001)
and longer stent length (26 &#x000b1; 18.4 vs. 33.48 &#x000b1; 22.8; p &#x0003c; 0.001) (<xref ref-type="table" rid="t01">Table 1</xref>).</p><p>The comparison of the radiological characteristics between both groups is expressed as
mean &#x000b1; standard deviation in <xref ref-type="table" rid="t02">Table 2</xref> and
illustrated in <xref ref-type="fig" rid="f01">Figure 1</xref>. Group 1 patients as
compared to Group 2 patients underwent a smaller amount of radiation expressed in Kerma
(Group 1: 3.4 &#x000b1; 12.6 Gy; Group 2: 9.3 &#x000b1; 60.8 Gy; p &#x0003c; 0.001) and DAP (Group 1: 119.7 &#x000b1;
70.7 Gycm<sup>2</sup>; Group 2: 139.2 &#x000b1; 75.3 Gycm<sup>2</sup>; p&#x000a0;&#x0003c;&#x000a0;0.001), a shorter
fluoroscopic time (Group 1: 16.5 &#x000b1; 10.1 minutes; Group 2: 22.4 &#x000b1; 14 minutes; p &#x0003c;
0.001), and a smaller number of acquisitions (Group 1: 26.3 &#x000b1; 9.6; Group 2: 31.6 &#x000b1; 10.9;
p &#x0003c; 0.001).</p><table-wrap id="t02" orientation="portrait" position="float"><label>Table 2</label><caption><p>Radiological characteristics of the procedures</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">Ad hoc (n = 320)</th><th align="center" rowspan="1" colspan="1">Staged (n = 248)</th><th align="center" rowspan="1" colspan="1">p value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Total Kerma (Gy)</td><td align="center" rowspan="1" colspan="1">3.4 &#x000b1; 12.6</td><td align="center" rowspan="1" colspan="1">9.3 &#x000b1; 60.8</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.001 <xref ref-type="table-fn" rid="TFN08">*</xref></td></tr><tr><td rowspan="1" colspan="1">Total DAP (Gycm<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">119.7 &#x000b1; 70.7</td><td align="center" rowspan="1" colspan="1">139.2 &#x000b1; 75.3</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.001 <xref ref-type="table-fn" rid="TFN08">*</xref></td></tr><tr><td rowspan="1" colspan="1">Total fluoroscopic time (min)</td><td align="center" rowspan="1" colspan="1">16.5 &#x000b1; 10.1</td><td align="center" rowspan="1" colspan="1">22.4 &#x000b1; 14.0</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.001 <xref ref-type="table-fn" rid="TFN08">*</xref></td></tr><tr><td rowspan="1" colspan="1">Total acquisition (number)</td><td align="center" rowspan="1" colspan="1">26.3 &#x000b1; 9.6</td><td align="center" rowspan="1" colspan="1">31.6 &#x000b1; 10.8</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.001 <xref ref-type="table-fn" rid="TFN08">*</xref></td></tr><tr><td rowspan="1" colspan="1">Kerma per lesion (Gy)</td><td align="center" rowspan="1" colspan="1">3.1 &#x000b1; 12.7</td><td align="center" rowspan="1" colspan="1">8.6 &#x000b1; 60.7</td><td align="center" rowspan="1" colspan="1">0.082</td></tr><tr><td rowspan="1" colspan="1">DAP per lesion (Gycm<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">106.3 &#x000b1; 67.3</td><td align="center" rowspan="1" colspan="1">112.1 &#x000b1; 68.9</td><td align="center" rowspan="1" colspan="1">0.145</td></tr><tr><td rowspan="1" colspan="1">Fluoroscopic time per lesion (min)</td><td align="center" rowspan="1" colspan="1">14.3 &#x000b1; 9</td><td align="center" rowspan="1" colspan="1">17.7 &#x000b1; 11.2</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.01</td></tr><tr><td rowspan="1" colspan="1">Acquisition per lesion (number)</td><td align="center" rowspan="1" colspan="1">23.2 &#x000b1; 9.6</td><td align="center" rowspan="1" colspan="1">25.2 &#x000b1; 10.2</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.01</td></tr></tbody></table><table-wrap-foot><fn id="TFN08"><label>*</label><p>Non-parametric Mann-Whitney U test; DAP: Dose-area product.</p></fn></table-wrap-foot></table-wrap><fig id="f01" orientation="portrait" position="float"><label>Figure 1 -</label><caption><p>Radiological characteristics of the procedures (p &#x0003c; 0.01). DAP: dose-area
product.</p></caption><graphic xlink:href="abc-105-05-0487-g01"/></fig><p><xref ref-type="table" rid="t03">Table 3</xref> compares patients according to their
number of lesions treated. Those having only one lesion treated were exposed to lower
radiation doses, and those having two or more lesions treated showed a tendency towards
lower doses.</p><table-wrap id="t03" orientation="portrait" position="float"><label>Table 3</label><caption><p>Radiological characteristics of the procedures, with stratification according to
the number of lesions treated</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">Ad hoc</th><th align="center" rowspan="1" colspan="1">Staged</th><th align="center" rowspan="1" colspan="1">p value</th></tr></thead><tbody><tr style="border-bottom-style:solid; border-bottom-width:thin"><td rowspan="1" colspan="1">
<bold>One lesion</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>(n = 260)</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>(n = 165)</bold>
</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">Total Kerma (Gy)</td><td align="center" rowspan="1" colspan="1">3.5 &#x000b1; 14.0</td><td align="center" rowspan="1" colspan="1">11.8 &#x000b1; 74.2</td><td align="center" rowspan="1" colspan="1">0.006<xref ref-type="table-fn" rid="TFN09">*</xref></td></tr><tr><td rowspan="1" colspan="1">Total DAP (Gycm2)</td><td align="center" rowspan="1" colspan="1">115.3 &#x000b1; 69.5</td><td align="center" rowspan="1" colspan="1">130.7 &#x000b1; 74.1</td><td align="center" rowspan="1" colspan="1">0.007<xref ref-type="table-fn" rid="TFN09">*</xref></td></tr><tr><td rowspan="1" colspan="1">Total fluoroscopic time (min)</td><td align="center" rowspan="1" colspan="1">15.3 &#x000b1; 9.3</td><td align="center" rowspan="1" colspan="1">20.1 &#x000b1; 12.1</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.001<xref ref-type="table-fn" rid="TFN09">*</xref></td></tr><tr><td rowspan="1" colspan="1">Total acquisition (number)</td><td align="center" rowspan="1" colspan="1">25.1 &#x000b1; 9.5</td><td align="center" rowspan="1" colspan="1">29.0 &#x000b1; 10.0</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.001<xref ref-type="table-fn" rid="TFN09">*</xref></td></tr><tr style="border-bottom-style:solid; border-bottom-width:thin; border-top-style:solid; border-top-width:thin"><td rowspan="1" colspan="1">
<bold>Two or more lesions</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>(n = 58)</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>(n = 83)</bold>
</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">Total Kerma (Gy)</td><td align="center" rowspan="1" colspan="1">2.9 &#x000b1; 1.3</td><td align="center" rowspan="1" colspan="1">4.3 &#x000b1; 8.9</td><td align="center" rowspan="1" colspan="1">0.103<xref ref-type="table-fn" rid="TFN09">*</xref></td></tr><tr><td rowspan="1" colspan="1">Total DAP (Gycm<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">141.6 &#x000b1; 72.5</td><td align="center" rowspan="1" colspan="1">156.1 &#x000b1; 75.1</td><td align="center" rowspan="1" colspan="1">0.203<xref ref-type="table-fn" rid="TFN09">*</xref></td></tr><tr><td rowspan="1" colspan="1">Total fluoroscopic time (min)</td><td align="center" rowspan="1" colspan="1">22.1 &#x000b1; 11.9</td><td align="center" rowspan="1" colspan="1">26.8 &#x000b1;1 6.4</td><td align="center" rowspan="1" colspan="1">0.121<xref ref-type="table-fn" rid="TFN09">*</xref></td></tr><tr><td rowspan="1" colspan="1">Total acquisition (number)</td><td align="center" rowspan="1" colspan="1">31.8 &#x000b1; 8.0</td><td align="center" rowspan="1" colspan="1">36.6 &#x000b1; 10.8</td><td align="center" rowspan="1" colspan="1">0.008<xref ref-type="table-fn" rid="TFN09">*</xref></td></tr></tbody></table><table-wrap-foot><fn id="TFN09"><label>*</label><p>Non-parametric Mann-Whitney U test; DAP: Dose-area product.</p></fn></table-wrap-foot></table-wrap><p><xref ref-type="table" rid="t04">Table 4</xref> shows the multiple regression analysis
for radiation exposure. The predictors related to the increase in radiation exposure
were the number of stents implanted (two or more) and the three-vessel pattern.</p><table-wrap id="t04" orientation="portrait" position="float"><label>Table 4</label><caption><p>Variables associated with the total dose-area product (Generalized Linear Model,
with gamma distribution and logarithmic link function), n = 566</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Variable</th><th align="center" rowspan="1" colspan="1">Coefficient</th><th align="center" rowspan="1" colspan="1">SE coef</th><th align="center" rowspan="1" colspan="1">p value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Number of stents (2-5)</td><td align="center" rowspan="1" colspan="1">0.301</td><td align="center" rowspan="1" colspan="1">0.049</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Angiographic characteristic
(three-vessel)</td><td align="center" rowspan="1" colspan="1">0.175</td><td align="center" rowspan="1" colspan="1">0.048</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Constant</td><td align="center" rowspan="1" colspan="1">4.646</td><td align="center" rowspan="1" colspan="1">0.035</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.001</td></tr></tbody></table><table-wrap-foot><fn id="TFN10"><p>SE coef: Standard error of the estimated coeffiaent</p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="discussion"><title>Discussion</title><p>The major finding of this study performed with consecutive patients undergoing
angioplasty in one single center was hat those submitted to the <italic>ad hoc</italic>
strategy as compared to those submitted to the staged strategy received a smaller amount
of radiation (expressed in Kerma and DAP) and had a shorter fluoroscopic time and a
smaller number of acquisitions.</p><p>The doses used were greater than those of previous studies<sup><xref rid="r06" ref-type="bibr">6</xref>,<xref rid="r08" ref-type="bibr">8</xref></sup>. Considering
only the doses used in angioplasties, previous studies have reported mean DAP of 55
Gycm<sup>2</sup> and 86.2 Gycm<sup>2</sup>, while, in this study, it was 119.7
Gycm<sup>2</sup>. In&#x000a0;addition to the greater complexity of the lesions treated
in&#x000a0;this study, with more three-vessel patients in both groups, that finding might relate
to the fact that the procedures were performed in one single academic institution,
involving interventional cardiology trainees, as already reported<sup><xref rid="r09" ref-type="bibr">9</xref>,<xref rid="r10" ref-type="bibr">10</xref></sup>.</p><p>Regarding the angiographic characteristics, a larger number of three-vessel patients was
observed in the staged procedure group. However, of the 320 Group 1 patients, 58 (18.1%)
had two or more lesions treated, while of the 248 Group 2 patients, 83 (33.5%) had two
or more lesions treated. Comparing both subgroups, a clear tendency towards a smaller
dose of radiation is observed in Group 1. This shows that, although Group 2 had a more
complex anatomy, it did not increase the radiation dose.</p><p>Regarding the characteristics of the procedure, Group 2 had more angioplasties of the
circumflex artery (CX), and a greater number of lesions treated and of stents implanted.
A&#x000a0;study with 1,827 patients undergoing angioplasty has shown that the complexity of the
lesion treated, angioplasty of the CX and number of lesions treated correlated with an
increase in the radiation dose<sup><xref rid="r11" ref-type="bibr">11</xref></sup>.
Another study involving 20,669 procedures has shown that the treatment of two or more
lesions correlated with an increase in radiation exposure<sup><xref rid="r12" ref-type="bibr">12</xref></sup>. Thus, the greater number of angioplasties of the CX and
of lesions approached in Group 2 may have increased the need for radiation observed in
that group. However, when assessing the radiation dose used per lesion treated, Group 1
maintained its advantage regarding lower dose, expressed as the fluoroscopic time and
number of acquisitions, with a clear tendency towards lower Kerma and DAP values per
lesion treated in that group.</p><p>Assessing the subgroup of patients having only one lesion treated (260 Group 1 patients
and 165 Group 2 patients), a significant difference was observed in the radiation dose
expressed in total Kerma (p = 0.006), total DAP (p = 0.007), total fluoroscopic time (p
&#x0003c; 0.001) and total number of acquisitions (p &#x0003c; 0.001), favoring Group 1.</p><p>Delewi et al. have reported that the increase in radiation exposure of patients
undergoing angioplasty and coronary angiography related to the following: body mass
index, history of coronary artery bypass graft surgery, number of lesions treated and of
chronic total occlusion lesions<sup><xref rid="r12" ref-type="bibr">12</xref></sup>. In
our study, the variables related to increased radiation exposure were the number of
stents implanted and the three-vessel pattern. Therefore, one may assume that patients
undergoing a staged procedure, with several and complex lesions to treat, especially
those obese and having previous coronary artery bypass graft surgery, might require a
high radiation dose and previous planning of the procedure, aimed at minimizing the
physician&#x02019;s and patient&#x02019;s radiation exposure. In addition, it is worth considering the
<italic>ad hoc</italic> procedure, mainly in the presence of other variables related
to increased radiation dose.</p><sec><title>Study limitations</title><p>This historical prospective study was conducted at one single center with data
collection from medical records.</p></sec></sec><sec sec-type="conclusions"><title>Conclusion</title><p>Ad hoc percutaneous coronary angioplasty, as compared to staged angioplasty, was
associated with a significant reduction in patient&#x02019;s radiation exposure even after
adjusting for baseline differences between groups, with smaller DAP and Kerma, shorter
fluoroscopic time and smaller number of acquisitions. Our findings suggest that lower
radiation doses can be seen as a potential benefit of <italic>ad hoc</italic>
angioplasty.</p></sec></body><back><fn-group><fn fn-type="con"><p>
<bold>Author contributions</bold>
</p><p>Conception and design of the research:Truffa MAM, Alves GMP, Bernardi F. Acquisition
of data:Truffa MAM, Alves GMP, Bernardi F. Analysis and interpretation of the data:
Truffa MAM. Statistical analysis: Truffa MAM. Obtaining financing: Truffa MAM.
Writing of the manuscript:Truffa MAM. Critical revision of the manuscript for
intellectual content: Truffa MAM, Alves GMP, Bernardi F, Esteves Filho A, Ribeiro E,
Galon MZ, Spadaro A, Kajita LJ, Arrieta R, Lemos PA.</p></fn><fn fn-type="conflict"><p>
<bold>Potential Conflict of Interest</bold>
</p><p>No potential conflict of interest relevant to this article was reported.</p></fn><fn fn-type="supported-by"><p>
<bold>Sources of Funding</bold>
</p><p>There were no external funding sources for this study.</p></fn><fn fn-type="other"><p>
<bold>Study Association</bold>
</p><p>This study is not associated with any thesis or dissertation work.</p></fn></fn-group><ref-list><title>References</title><ref id="r01"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chambers</surname><given-names>CE</given-names></name><name><surname>Fetterly</surname><given-names>KA</given-names></name><name><surname>Holzer</surname><given-names>R</given-names></name><name><surname>Lin</surname><given-names>PJ</given-names></name><name><surname>Blankenship</surname><given-names>JC</given-names></name><name><surname>Balter</surname><given-names>S</given-names></name><etal/></person-group><article-title>Radiation safety program for the cardiac catheterization
laboratory</article-title><source>Catheter Cardiovasc Interv</source><year>2011</year><volume>77</volume><issue>4</issue><fpage>546</fpage><lpage>556</lpage><pub-id pub-id-type="pmid">21254324</pub-id></element-citation></ref><ref id="r02"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valentin</surname><given-names>J</given-names></name></person-group><article-title>Avoidance of radiation injuries from medical interventional
procedures</article-title><source>Ann ICRP</source><year>2000</year><volume>30</volume><issue>2</issue><fpage>7</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">11459599</pub-id></element-citation></ref><ref id="r03"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balter</surname><given-names>S</given-names></name><name><surname>Hopewell</surname><given-names>JW</given-names></name><name><surname>Miller</surname><given-names>DL</given-names></name><name><surname>Wagner</surname><given-names>LK</given-names></name><name><surname>Zelefsky</surname><given-names>MJ</given-names></name></person-group><article-title>Fluoroscopically guided interventional procedures: a review of
radiation effects on patients' skin and hair</article-title><source>Radiology</source><year>2010</year><volume>254</volume><issue>2</issue><fpage>326</fpage><lpage>341</lpage><pub-id pub-id-type="pmid">20093507</pub-id></element-citation></ref><ref id="r04"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molyvda-Athanasopoulou</surname><given-names>E</given-names></name><name><surname>Karlatira</surname><given-names>M</given-names></name><name><surname>Gotzamani-Psarrakou</surname><given-names>A</given-names></name><name><surname>Koulouris</surname><given-names>C</given-names></name><name><surname>Siountas</surname><given-names>A</given-names></name></person-group><article-title>Radiation exposure to patients and radiologists during interventional
procedures</article-title><source>Radiat Prot Dosimetry</source><year>2011</year><volume>147</volume><issue>1-2</issue><fpage>86</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">21765154</pub-id></element-citation></ref><ref id="r05"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cusma</surname><given-names>JT</given-names></name><name><surname>Bell</surname><given-names>MR</given-names></name><name><surname>Wondrow</surname><given-names>MA</given-names></name><name><surname>Taubel</surname><given-names>JP</given-names></name><name><surname>Holmes</surname><given-names>DR</given-names><suffix>Jr</suffix></name></person-group><article-title>Real-time measurement of radiation exposure to patients during
diagnostic coronary angiography and percutaneous interventional
procedures</article-title><source>J Am Coll Cardiol</source><year>1999</year><volume>33</volume><issue>2</issue><fpage>427</fpage><lpage>435</lpage><pub-id pub-id-type="pmid">9973023</pub-id></element-citation></ref><ref id="r06"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delichas</surname><given-names>MG</given-names></name><name><surname>Psarrakos</surname><given-names>K</given-names></name><name><surname>Molyvda-Athanassopoulou</surname><given-names>E</given-names></name><name><surname>Giannoglou</surname><given-names>G</given-names></name><name><surname>Hatziioannou</surname><given-names>K</given-names></name><name><surname>Papanastassiou</surname><given-names>E</given-names></name></person-group><article-title>Radiation doses to patients undergoing coronary angiography and
percutaneous transluminal coronary angioplasty</article-title><source>Radiat Prot Dosimetry</source><year>2003</year><volume>103</volume><issue>2</issue><fpage>149</fpage><lpage>154</lpage><pub-id pub-id-type="pmid">12593434</pub-id></element-citation></ref><ref id="r07"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakalyar</surname><given-names>DM</given-names></name><name><surname>Castellani</surname><given-names>MD</given-names></name><name><surname>Safian</surname><given-names>RD</given-names></name></person-group><article-title>Radiation exposure to patients undergoing diagnostic and
interventional cardiac catheterization procedures</article-title><source>Cathet Cardiovasc Diagn</source><year>1997</year><volume>42</volume><issue>2</issue><fpage>121</fpage><lpage>125</lpage><pub-id pub-id-type="pmid">9328690</pub-id></element-citation></ref><ref id="r08"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mesbahi</surname><given-names>A</given-names></name><name><surname>Aslanabadi</surname><given-names>N</given-names></name></person-group><article-title>A study on patients' radiation doses from interventional cardiac
procedures in Tabriz, Iran</article-title><source>Radiat Prot Dosimetry</source><year>2008</year><volume>132</volume><issue>4</issue><fpage>375</fpage><lpage>380</lpage><pub-id pub-id-type="pmid">19106178</pub-id></element-citation></ref><ref id="r09"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lo</surname><given-names>TS</given-names></name><name><surname>Zaman</surname><given-names>AG</given-names></name><name><surname>Stables</surname><given-names>R</given-names></name><name><surname>Fraser</surname><given-names>D</given-names></name><name><surname>Oldryod</surname><given-names>KG</given-names></name><name><surname>Hildick-Smith</surname><given-names>D</given-names></name><etal/></person-group><article-title>Comparison of operator radiation exposure with optimized radiation
protection devices during coronary angiograms and ad hoc percutaneous coronary
interventions by radial and femoral routes</article-title><source>Eur Heart J</source><year>2008</year><volume>29</volume><issue>17</issue><fpage>2180</fpage><lpage>2180</lpage><pub-id pub-id-type="pmid">18562304</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lo</surname><given-names>TS</given-names></name><name><surname>Ratib</surname><given-names>K</given-names></name><name><surname>Chong</surname><given-names>AY</given-names></name><name><surname>Bhatia</surname><given-names>G</given-names></name><name><surname>Gunning</surname><given-names>M</given-names></name><name><surname>Nolan</surname><given-names>J</given-names></name></person-group><article-title>Impact of access site selection and operator expertise on radiation
exposure; a controlled prospective study</article-title><source>Am Heart J</source><year>2012</year><volume>164</volume><issue>4</issue><fpage>455</fpage><lpage>461</lpage><pub-id pub-id-type="pmid">23067901</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fetterly</surname><given-names>KA</given-names></name><name><surname>Lennon</surname><given-names>RJ</given-names></name><name><surname>Bell</surname><given-names>MR</given-names></name><name><surname>Holmes</surname><given-names>DR</given-names><suffix>Jr</suffix></name><name><surname>Rihal</surname><given-names>CS</given-names></name></person-group><article-title>Clinical determinants of radiation dose in percutaneous coronary
interventional procedures: influence of patient size, procedure complexity, and
performing physician</article-title><source>JACC Cardiovasc Interv</source><year>2011</year><volume>4</volume><issue>3</issue><fpage>336</fpage><lpage>343</lpage><pub-id pub-id-type="pmid">21435613</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delewi</surname><given-names>R</given-names></name><name><surname>Hoebers</surname><given-names>LP</given-names></name><name><surname>Ramunddal</surname><given-names>T</given-names></name><name><surname>Henriques</surname><given-names>JP</given-names></name><name><surname>Anger&#x000e5;s</surname><given-names>O</given-names></name><name><surname>Stewart</surname><given-names>J</given-names></name><etal/></person-group><article-title>Clinical and procedural characteristics associated with higher
radiation exposure during percutaneous coronary interventions and coronary
angiography</article-title><source>Circ Cardiovasc Interv</source><year>2013</year><volume>6</volume><issue>5</issue><fpage>501</fpage><lpage>506</lpage><pub-id pub-id-type="pmid">24065442</pub-id></element-citation></ref></ref-list></back></article>